Viewing Study NCT04098068

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:46 PM
Ignite Modification Date: 2026-07-19 @ 2:17 AM
Study NCT ID: NCT04098068
Status: COMPLETED
Last Update Posted: 2025-03-30
First Post: 2019-09-19
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of MK-3475 (Pembrolizumab) in Patients With Microsatellite Unstable (MSI) Tumors (Cohort D)
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None High Tumor Mutation Burden View
None High TMB (Tumor Mutation Burden) View
None MSS (Microsatellite Stable) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None TMB (Tumor Mutation Burden) View
None Mutation load View
None Tumor mutation load View
None Mutation burden View
None Tumor mutation burden (TMB) View
None Hypermutation View
None MSI Negative with Mutator Phenotype (High Tumor Mutation Burden) View